Health care situation in patients with allergic respiratory diseases with special focus on specific immunotherapy
- PDF / 293,044 Bytes
- 7 Pages / 595 x 842 pts (A4) Page_size
- 5 Downloads / 175 Views
Allergo J Int https://doi.org/10.1007/s40629-020-00149-z
Health care situation in patients with allergic respiratory diseases with special focus on specific immunotherapy Frederik Valbert · Silke Neusser · Cordula Riederer · Stefanie Wobbe-Ribinski · Ludger Klimek · Annette Sperl · Oliver Pfaar · Thomas Werfel · Eckard Hamelmann · Anja Neumann · Jürgen Wasem · Janine Biermann-Stallwitz
Received: 21 July 2020 / Accepted: 9 September 2020 © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2020
Summary Background Allergic respiratory diseases have an impact on the performance and quality of life of the patients. The allergen immunotherapy (AIT) is the only causal treatment approach with the chance to positively influence the course of the disease. However, differentiated figures for the treatment of suitable patients in Germany are still missing. Methods The health care situation in Germany is examined with a retrospective, cross-sectional, cohortbased health care analysis based on patient data and routine data from statutory health insurance (SHI). F. Valbert and S. Neusser share first authorship. F. Valbert () · S. Neusser · A. Neumann · J. Wasem · J. Biermann-Stallwitz Institute for Healthcare Management and Research, University Duisburg-Essen, Essen, Germany [email protected] C. Riederer · S. Wobbe-Ribinski Department of Health Services Research, DAK-Gesundheit, Hamburg, Germany L. Klimek · A. Sperl Center for Rhinology and Allergology, Wiesbaden, Germany O. Pfaar Section Rhinology and Allergology, University Hospital Marburg, Marburg, Germany T. Werfel Clinic for Dermatology, Allergology and Venerology, Hannover Medical School, Hanover, Germany E. Hamelmann Clinic for Child and Youth Medicine, Evangelical Hospital Bethel, Bielefeld, Germany F. Valbert Chair of Medical Management, University of Duisburg-Essen, Thea-Leymann-Straße 9, 45127 Essen, Germany
K
Characteristics are identified that encourage or prevent guideline-based care. In addition, data on quality of life and costs of illness of allergic rhinitis and allergic asthma are collected and evaluated. Results Routine data provide comprehensive and cross-sectoral information about diagnoses and utilization of health care services. In addition, primary data give information on disease severity, treatment history, quality of life, use of alternative treatment methods, and sociodemographic characteristics of the patients. Conclusion Analysis of the care situation with regard to the specific immunotherapy in cases of allergic respiratory diseases (VerSITA) provides a solid basis for future research and for informing decision-makers in order to develop measures to optimize care. Keywords AIT · Allergen immunotherapy · Health services research · Asthma · Rhinitis Abbreviations AA Allergic Bronchial Asthma (study group) ACT Asthma control test AIT Allergen immunotherapy AR Allergic Rhinitis (study group) AR & AA Allergic Rhinitis and Allergic Bronchial Asthma (study group) ATC Anatomical therapeutic chemical DLR German Aerospace Cen
Data Loading...
